These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4917111)

  • 1. Analysis of a trial of dapsone vs placebo in lepromatous leprosy.
    Levy L; Murray LP
    Int J Lepr Other Mycobact Dis; 1967; 35(3):393-4. PubMed ID: 4917111
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapeutic trials in leprosy. 2. Comparative trial of dapsone plus ditophal (Etisul) and dapsone alone in the treatment of lepromatous leprosy.
    Waters MF; Pettit JH
    Int J Lepr; 1965; 33(3):280-96. PubMed ID: 5322767
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
    Waters MF; Rees RJ; Sutherland I
    Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trial with rifampicin in the treatment of leprosy.
    Ghosh S; Hazra SK; Kundu S; Choudhury S
    Lepr India; 1976 Oct; 48(4 Suppl):775-80. PubMed ID: 800236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dapsone resistant leprosy, the western Kenya experience.
    Orege PA; Owili DM
    Trop Geogr Med; 1985 Jun; 37(2):139-42. PubMed ID: 4035777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
    Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current state of thalidomide treatment of leprosy and leprosy reaction].
    Sheskin J; Sagher F
    Arch Klin Exp Dermatol; 1970; 237(1):312-6. PubMed ID: 4906813
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical evaluation studies in lepromatous leprosy. Sixth series: effect (on lepra reaction) of supplementing DDS with dexamethasone, methandrostenolone, or mefenamic acid.
    Doull JA; Tolentino JG; Guinto RS; Rodriguez JN; Leano LM; Fernandez JV; Rivera JN; Fajardo TT
    Int J Lepr Other Mycobact Dis; 1967; 35(2):128-39. PubMed ID: 5338957
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pilot-trial of treatment of leprosy by pig's thymosin combined with dapsone (author's transl)].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Sep; 3(3):198-200. PubMed ID: 6459183
    [No Abstract]   [Full Text] [Related]  

  • 12. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
    Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ
    Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585
    [No Abstract]   [Full Text] [Related]  

  • 13. Blind trial of weekly doses of sulforthomidine (fanasil (Roche)) and Disulone in lepromatous leprosy. Comparison of results after thirty months of treatment.
    Languillon J
    Int J Lepr Other Mycobact Dis; 1971; 39(2):471-5. PubMed ID: 4948086
    [No Abstract]   [Full Text] [Related]  

  • 14. A preliminary report on a therapeutic trial with acedapsone in lepromatous leprosy.
    Ramanujam K; Iyer CG; Ramu G
    Lepr Rev; 1975 Jun; 46(2 Suppl):85-7. PubMed ID: 1100969
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trial with CIBA 1906 in lepromatous leprosy.
    Anand LC; Tiwari VD; Rathore BS; Singh O
    Lepr India; 1981 Apr; 53(2):278-84. PubMed ID: 7019567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy.
    Williams TW; Mott PD; Wertlake PT; Rubio JB; Adler RC; Hill GJ; Suarez GP; Knight V
    Int J Lepr; 1965; 33(3):Suppl:767-77. PubMed ID: 5322715
    [No Abstract]   [Full Text] [Related]  

  • 17. A clinical trial of sulforthomidine ('Fanasil' Roche) in lepromatous leprosy.
    Currie G
    Lepr Rev; 1966 Oct; 37(4):205-8. PubMed ID: 5341699
    [No Abstract]   [Full Text] [Related]  

  • 18. A report on a controlled clinical trial with conventional and one third conventional dose of dapsone administered orally once a week in lepromatous patients.
    Ramanujam K; Iyer CG; Ramu G
    Lepr Rev; 1975 Jun; 46(2 Suppl):93-7. PubMed ID: 1100971
    [No Abstract]   [Full Text] [Related]  

  • 19. Intermittent rifampicin therapy in lepromatous leprosy.
    Girdhar BK; Sreevatsa ; Desikan KV
    Lepr India; 1980 Jan; 52(1):89-96. PubMed ID: 6991816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dapsone on blood lactic and pyruvic acids in leprosy.
    Sinha SN; Gupta SC; Bajaj AK; Srivastava NP; Mehrotra TN
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):468-70. PubMed ID: 6892022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.